Sıçanlarda Hepatik İskemi Reperfüzyon Hasarında Farklı Dozlarda Amantadin'in Akciğer Dokusu Üzerine Etkisi
Amaç: N-Metil D-Aspartat (NMDA) reseptör blokerlerinin çeşitli dokularda iskemi/reperfüzyon (I/R) hasarına karşı koruyucu etkileri olduğu gösterilmiştir. Bu çalışmanın amacı, hepatik I/R hasarında 90 ve 135 mg/kg dozlarındaki amantadinin akciğer üzerindeki etkilerini araştırmaktır.
Gereç ve Yöntem: Sıçanlar her rastgele altı gruba ayrıldı: Grup Sham, Grup I/R, Grup Amantadin-90, Grup Amantadin-135, Grup I/R-90 ve Grup I/R-135. I/R'de sol portal triaddaki yapılara 45 dakika süre ile atravmatik vasküler klemp uygulandı ve iskemi sonrası 2 saat reperfüzyon uygulandı. Akciğer dokusunda malondialdehit (MDA), süperoksit dismutaz (SOD) ve katalaz (CAT) enzim düzeyleri ölçüldü ve dokular histopatolojik olarak incelendi.
Bulgular: MDA, SOD, CAT düzeyleri açısından gruplar arasında anlamlı fark bulundu (sırasıyla; p
The Effect of Different Doses of Amantadine on Lung Tissue In Hepatıc Ischemia Reperfusion Injury in Rats
Objective: N-Methyl D-Aspartate (NMDA) receptor blockers have been shown to have protective effects against ischemia/reperfusion (I/R) injury in various tissues. The aim of this study was to investigate the effects of 90 ve 135 mg/kg doses of amantadine on lung in hepatic I/R injury.
Method: The rats were randomly divided into six groups: Group Sham, Group I/R, Group Amantadine-90, Group Amantadine-135, Group I/R-90 and Group I/R-135. In I/R, an atraumatic vascular clamp was applied to the structures in the left portal triad for 45 minutes and reperfusion period was 2 hours after ischemia. Malondialdehyde (MDA), superoxide dismutase (SOD) and catalase (CAT) enzyme levels were performed the lung tissue and tissues were examined histopathologically.
Result: A significant difference was found between the groups in terms of MDA, SOD, CAT levels (respectively; p
___
- 1. Konishi T, Lentsch AB. Hepatic Ischemia/Reperfusion: Mechanisms of Tissue Injury, Repair and Regeneration. Gene Expr 2017; 17(4): 277-87.
- 2. Kalogeris T, Baines CP, Krenz M, Korthuis RJ. Ischemia/reperfusion. Compr. Physiol 2016; 7: 113
- 3. Peralta C, Jiménez-Castro MB, Gracia-Sancho J. Hepatic ischemia and reperfusion injury: effects on the liver sinusoidal milieu. J. Hepatol 2013; 59: 1094-106.
- 4. Miranda LC, Capellini V, Reis G, Celotto A , Carlotti Jr C, Evora PR. Effects of partial liver ischemia followed by global liver reperfusion on the remote tissue expression of nitric oxide synthase:lungs and kidneys. Transplant Proc 2010 Jun; 42(5): 1557-62.
- 5. Tufek A, Tokgoz O, Aliosmanoglu I, et al. The protective effects of dexmedetomidine on the liver and remote organs against hepatic ischemia reperfusion injury in rats. Int J Surg 2013; 11(1): 96-100.
- 6. Sun H, Zou S, Candiotti KA, et al. Octreotide attenuates acute kidney injury after hepatic ischemia and reperfusion by enhancing autophagy. Sci Rep 2017; 7: 42701.
- 7. Zhou L, Zhao D, An H, Zhang H, Jiang C, Yang B. Melatonin prevents lung injury induced by hepatic ischemia–reperfusion through anti-inflammatory and anti-apoptosis effects. Int Immunopharmacol 2015 Dec; 29(2): 462-7.
- 8. Nakamura K, Yazawa T, Kawaguchi Y, et al. High tidal volume ventilation induces lung injury after hepatic ischemia-reperfusion. Am J Physiol Lung Cell Mol Physiol 2007; 292: 625-31.
- 9. Okigbo AA, Helkowski MS, Royes BJ, et al. Dose-dependent neurorestorative effects of amantadine after cortical impact injury. Neurosci Lett 2019: Feb 16; 694:69-73.
- 10. Yamanaka K, Houben P, Bruns H, Schultze D, Hatano E, Schemmer P. A Systematic review of pharmacological treatment options used to reduce ischemia reperfusion injury in rat liver transplantation. PLoS One 2015; 10(4): e0122214.
- 11. Himmelseher S, Durieux, M.E. Revising a dogma: ketamine for patients with neurological injury. Anesth Analg 2005: 101; 524-53.
- 12. Lee HT, Ota-Setlik A, Fu Y, Nasr SH, Emala CW. Differential protective effects of volatile anesthetics against renal ischemia–reperfusion injury in vivo. Anesthesiology 2004: 101; 1313-24.
- 13. Kato R, Foëx P. Myocardial protection by anesthetic agents against ischemia–reperfusion injury: an update for anesthesiologists. Can J Anaesth 2002: 49(8), 777-91.
- 14. Orhan M, Tuna Taş A, Ünal Y, Arslan M, Yazar H, Sezen Cem Ş, et al. The effects of amantadine on lung tissue in lower limb ischemia/reperfusion injury model in rats. Turk Gogus Kalp Dama 2021;29:077-083
- 15. Sehirli O, Ozel Y, Dulundu E, Topaloglu U, Ercan F, Sener G. Grape seed extract treatment reduces hepatic ischemia-reperfusion injury in rats. Phytother Res 2008 Jan; 22(1): 43-8.
- 16. Cámara-Lemarroy CR, Guzmán-de la Garza FJ, Alarcón-Galván G, Cordero-Pérez P, Fernández-Garza NE: The effects of NMDA receptor antagonists over intestinal ischemia/reperfusion injury in rats. Eur J Pharmacol 2009; 621: 78–85.
- 17. Ke T, Li R, Chen W. Inhibition of the NMDA receptor protects the rat sciatic nerve against ischemia/reperfusion injury. Experimental and Therapeutic Medicine 2016; 11: 1563-72.
- 18. Takhtfooladi MA, Jahanshahi A, Sotoudeh A, Daneshi MH, Khansari M, Takhtfooladi HA. The antioxidant role of N-acetylcysteine on the testicular remote injury after skeletal muscle ischemia and reperfusion in rats. Pol J Pathol 2013; 64(3): 204-9.
- 19. Sahin T, Begeç Z, Toprak Hİ, et al. The effects of dexmedetomidine on liver ischemia-reperfusion injury in rats. J Surg Res 2013 Jul; 183(1): 385-90
- 20. Kireev R, Bitoun S, Cuesta S, et al. Melatonin treatment protects liver of Zucker rats after ischemia/reperfusion by diminishing oxidative stress and apoptosis. Eur J Pharmacol 2013; 701: 185-93.
- 21. Mates JM, Perez-Gomez C, Castro IN. Antioxidant enzymes and human disease. Clin Biochem 1999; 32(8): 595-603.
- 22. Kucuk A, Yaylak F, Cavunt- Bayraktar A, et al. The protective effects of dexmedetomidine on hepatic ischemia reperfusion injury. Bratisl Lek Listy 2014; 115(11); 680-4.
- 23. Kapan S, KiriS I, Kılbas A, Altuntas I, Karahan N, Okutan H. The effect of erythropoietin on lung injury in rat aortic ischemia-reperfusion. Turkish J Thorac Cardiovasc Surg 2009; 17(2): 110-6.
- 24. Gu, J, Korteweg, C. Pathology and pathogenesis of severe acute respiratory syndrome. Am J Pathol 2007; 170(4): 1136-47.
- 25. Aduen JF, Stapelfeldt WH, Johnson MM, et al. Clinical relevance of time of onset, duration, and type of pulmonary edema after liver transplantation. Liver Transplant 2003 Jul; 9(7); 764-71.
- 26. El-Sayed LA, Osama E, Mehesen MN, et al. Contribution of angiotensin II in hepatic ischemia /reperfusion induced lung injury: Acute versus chronic usage of captopril. Pulmonary Pharmacology & Therapeutics 2020; 60: 101888.
- 27. Canedo LF, Lima GV, Machado MCC. Pulmonary effects after partial liver ischemia and reperfusion – experimental model. Revista Do Colegio Brasileiro De Cirurgioes. 2012; 39(3): 216-21.